These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 16149460)

  • 1. [Interferon (IFN)-alpha, beta, gamma].
    Uno K
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():89-92. PubMed ID: 16149460
    [No Abstract]   [Full Text] [Related]  

  • 2. Determination of 2'-5'-oligoadenylate synthetase in serum and peripheral blood mononuclear cells before and after subcutaneous application of recombinant interferon beta and gamma.
    Bruchelt G; Fierlbeck G; Schiebel U; Bogenschütz O; Rassner G; Niethammer D
    Eur J Clin Chem Clin Biochem; 1992 Sep; 30(9):521-8. PubMed ID: 1457613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [2' 5'-oligoadenylate synthetase (2-5AS)].
    Kaneko S; Sakai A
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():812-4. PubMed ID: 15658457
    [No Abstract]   [Full Text] [Related]  

  • 4. Interferon-induced proteins are elevated in blood samples of patients with chemically or virally induced chronic fatigue syndrome.
    Vojdani A; Lapp CW
    Immunopharmacol Immunotoxicol; 1999 May; 21(2):175-202. PubMed ID: 10319275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon-induced 2'-5' adenylate synthetase in vivo and interferon production in vitro by lymphocytes from systemic lupus erythematosus patients with and without circulating interferon.
    Preble OT; Rothko K; Klippel JH; Friedman RM; Johnston MI
    J Exp Med; 1983 Jun; 157(6):2140-6. PubMed ID: 6189954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2',5'-oligoadenylate synthetase induction in lymphocytes of patients with connective tissue diseases.
    Hylton W; Cayley J; Dore C; Denman AM
    Ann Rheum Dis; 1986 Mar; 45(3):220-4. PubMed ID: 3954470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Serum 2-5 oligoadenylate synthetase activity in infectious diseases and collagen diseases in childhood].
    Arai T; Yamamoto H; Sakamoto M; Eda N; Matsumoto T; Ikei K; Hashimoto H; Seki T; Ohtani T; Ohishi T
    Kaku Igaku; 1991 Feb; 28(2):197-203. PubMed ID: 2051656
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical significance of 2-5 oligoadenylate synthetase analysis in blood cell chemical analysis].
    Kato Y; Hattori N
    Nihon Rinsho; 1989 Dec; 48 Suppl():963-6. PubMed ID: 2482910
    [No Abstract]   [Full Text] [Related]  

  • 9. Interferon and 2-5A synthetase in patients with immune diseases.
    Preble OT; Yeh TJ; Silverman RH; Klippel JH; Straus SE; Gelmann EP
    Prog Clin Biol Res; 1985; 202():415-22. PubMed ID: 2421319
    [No Abstract]   [Full Text] [Related]  

  • 10. A bioassay for serum interferon based on induction of 2'5'-oligoadenylate synthetase activity.
    Uno K; Sato T; Takada Y; Fujioka K; Suginoshita Y; Kakimi K; Moriyasu F; Kishida T
    J Interferon Cytokine Res; 1998 Dec; 18(12):1011-8. PubMed ID: 9877443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of 2'-5' oligoadenylate synthetase during interferon treatment of chronic myelogenous leukemia.
    Moritz T; Weissmann B; Grünewald B; Hust H; Kummer G; Niederle N
    Mol Biother; 1992 Jun; 4(2):97-102. PubMed ID: 1381190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of type I interferon production.
    Seeds RE; Miller JL
    Curr Protoc Immunol; 2011 Feb; Chapter 14():Unit14.21.1-11. PubMed ID: 21400681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical value of the determination of an interferon-induced enzyme activity: studies of the 2'5' oligoadenylate synthetase activity in peripheral blood lymphocytes of patients.
    Chousterman S; Chousterman M; Reinert P; Thang MN
    Biomed Pharmacother; 1983; 37(4):176-80. PubMed ID: 6198003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [2-5 Oligoadenylate synthetase].
    Koura T; Kato Y; Unoura M
    Nihon Rinsho; 1995 Mar; 53 Su Pt 2():202-5. PubMed ID: 8753217
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum levels of 2',5 oligoadenylate synthetase during interferon therapy in patients with B-cell chronic lymphocytic leukemia.
    Musolino C; Grosso P; Alonci A; Allegra A; Orlando A; Cincotta M; Buda G; Squadrito G
    Am J Hematol; 1993 May; 43(1):1-4. PubMed ID: 8317456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum levels of soluble interferon Alfa/Beta receptor as an inhibitory factor of interferon in the patients with chronic hepatitis C.
    Mizukoshi E; Kaneko S; Kaji K; Terasaki S; Matsushita E; Muraguchi M; Ohmoto Y; Kobayashi K
    Hepatology; 1999 Nov; 30(5):1325-31. PubMed ID: 10534358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CpG oligodeoxynucleotide induction of antiviral effector molecules in sheep.
    Nichani AK; Kaushik RS; Mena A; Popowych Y; Dent D; Townsend HG; Mutwiri G; Hecker R; Babiuk LA; Griebel PJ
    Cell Immunol; 2004 Jan; 227(1):24-37. PubMed ID: 15051512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon-alpha and -gamma expression in the rat testis.
    Dejucq N; Dugast I; Ruffault A; van der Meide PH; Jégou B
    Endocrinology; 1995 Nov; 136(11):4925-31. PubMed ID: 7588226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum concentrations of 2',5'-oligoadenylate synthetase, neopterin, and beta-glucan in patients with chronic fatigue syndrome and in patients with major depression.
    Matsuda J; Gohchi K; Gotoh N
    J Neurol Neurosurg Psychiatry; 1994 Aug; 57(8):1015-6. PubMed ID: 8057103
    [No Abstract]   [Full Text] [Related]  

  • 20. Biological and clinical effects of the combination of beta- and gamma-interferons administered as a 5-day continuous infusion.
    Schiller JH; Storer B; Witt PL; Nelson B; Brown RR; Horisberger M; Grossberg S; Borden EC
    Cancer Res; 1990 Aug; 50(15):4588-94. PubMed ID: 2114942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.